News
Sino-Pack2020 and PACKINNO2020 will be further postponed from June 2020 to March 2021
Postponement of the 27th China International Exhibition on Packaging Machinery & Materials (Sino-Pack2020) cum China (Guangzhou) International Exhibition on Packaging Products (PACKINNO2020)
Since the occurrence of COVID-19, we have been closely monitoring the situation. On 8th April 2020, the State...
News
Bio-Rad Begins Shipping COVID-19 Antibody Test
Bio-Rad Laboratories has launched its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease. Bio-Rad has applied for Emergency Use Authorization offered by...
News
Q BioMed, Mannin Research Accelerate COVID-19 Response Initiatives
Q BioMed Inc., and its technology partner, Mannin Research, are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused by COVID-19 and other viral infections. The drug program is being evaluated by government programs...
News
Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus
Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd., has entered into a collaboration agreement with Akshaya Bio, a Canadian development stage biotechnology company to provide rapid access...
Clinical Trials
Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
This clinical trial, led by Professor Danny McAuley and Professor Cecilia O’Kane, both researchers from the...
Clinical Trials
Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late April
Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning by late April. The two companies began their collaboration focused on developing a vaccine for...
News
CirrusDx Laboratory receives emergency use authorisation from FDA for COVID-19 testing
CirrusDx validated and will commercialize the Allplex 2019-nCoV Assay, a real-time Reverse Transcriptase PCR test developed by Seegene, a South Korea-based global leader in multiplex molecular diagnostics.
Cirrus Dx, an infectious disease laboratory and diagnostics company, received Emergency Use Authorization...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














